Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Jeremy Fulop, M.D.

Concepts (23)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Pancreatic Ductal1202317080.390 Why?
Pancreatic Neoplasms1202353100.250 Why?
Deoxycytidine120238600.160 Why?
Fluorouracil1202316200.150 Why?
Stomach120196970.120 Why?
Antitubercular Agents1201913740.090 Why?
Drug Delivery Systems1201922180.070 Why?
Anti-Bacterial Agents2202373800.070 Why?
Tuberculosis1201920020.070 Why?
Medicare1202367630.060 Why?
Antineoplastic Combined Chemotherapy Protocols12023116530.050 Why?
Cohort Studies12023412470.040 Why?
Doxycycline120193360.040 Why?
Delayed-Action Preparations120199610.030 Why?
United States12023722370.030 Why?
Retrospective Studies12023801210.030 Why?
Aged120231686170.020 Why?
Swine1201959030.020 Why?
Dose-Response Relationship, Drug12019108270.020 Why?
Male120233587190.020 Why?
Female120233902400.010 Why?
Humans220237592550.010 Why?
Animals120191678380.000 Why?
Fulop's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (23)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.